603456.SS SHH
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
1W: +3.4%
1M: +10.3%
3M: +15.4%
YTD: -7.0%
1Y: -7.8%
3Y: -31.9%
5Y: -58.0%
¥16.75 ($2.50)
+0.49 (+3.01%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$992M
-27.1% ▼
5Y CAGR: +12.3%
Capital Expenditures
$889M
+4.4% ▲
5Y CAGR: +22.6%
Free Cash Flow
$103M
-76.2% ▼
5Y CAGR: -15.2%
Dividends Paid
$471M
-31.4% ▼
Buybacks
$130M
-99.7% ▼
Net Change in Cash
-$482M
-120.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $380M | $634M | $921M | $1.0B | $607M |
| Depreciation & Amort. | $252M | $292M | $348M | $382M | $411M |
| Stock-Based Comp. | $7M | $20M | $35M | $0 | $0 |
| Change in Working Capital | -$319M | -$308M | -$100M | -$206M | -$290M |
| Other Non-Cash Items | $54M | $16M | $15M | $153M | $264M |
| Operating Cash Flow | $400M | $678M | $1.2B | $1.4B | $992M |
| — Investing Activities — | |||||
| Capital Expenditures | -$316M | -$580M | -$714M | -$929M | -$889M |
| Acquisitions (Net) | $43M | $8M | -$31M | -$109M | $0 |
| Investment Purchases | -$13M | -$70M | -$15M | -$41M | -$25M |
| Investment Sales | $8M | $60M | $24M | $0 | $22M |
| Other Investing | $68M | -$184M | -$2M | $23M | $10M |
| Investing Cash Flow | -$211M | -$765M | -$738M | -$1.1B | -$881M |
| — Financing Activities — | |||||
| Net Debt Issuance | $65M | -$239M | -$362M | $63M | -$637K |
| Stock Repurchased | -$246M | -$8M | -$54M | -$65M | -$130M |
| Dividends Paid | -$161M | -$166M | -$209M | -$359M | -$471M |
| Other Financing | $225M | $996M | $16M | $2.5B | -$7M |
| Financing Cash Flow | -$116M | $582M | -$609M | $2.1B | -$610M |
| Net Change in Cash | $22M | $472M | -$64M | $2.4B | -$482M |
| Cash End of Period | $255M | $727M | $663M | $3.1B | $2.6B |
| Free Cash Flow | $85M | $98M | $512M | $431M | $103M |